Medpace Holdings, Inc. Amortization of Debt Issuance Costs and Discounts
Medpace Holdings, Inc. (MEDP) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2022-02-15
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-12-31 was $0.00.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2021 was $0.00.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2019 was $954.00K, a 55.12% increase from fiscal 2018.
- Medpace Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2018 was $615.00K, a 7.10% decline from fiscal 2017.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 10-K · filed 2022-02-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $0.00 derived: sum of 2 quarters · filed 2020-10-27 | $0.00 10-Q · filed 2020-10-27 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $0.00 10-Q · filed 2020-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $80.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $80.00K derived: sum of 3 quarters · filed 2022-02-15 | $816.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $80.00K derived: sum of 2 quarters · filed 2022-02-15 | $816.00K derived: sum of 3 quarters · filed 2022-02-15 | $954.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $816.00K derived: sum of 2 quarters · filed 2020-10-27 | $954.00K 10-Q · filed 2020-10-27 | $1.10M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $874.00K 10-Q · filed 2020-07-28 | $1.02M derived: sum of 3 quarters · filed 2021-02-16 | $1.17M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $138.00K 10-Q · filed 2020-04-29 | $282.00K derived: sum of 2 quarters · filed 2021-02-16 | $436.00K derived: sum of 3 quarters · filed 2021-02-16 | $594.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $298.00K derived: sum of 2 quarters · filed 2021-02-16 | $456.00K derived: sum of 3 quarters · filed 2021-02-16 | $615.00K 10-K · filed 2021-02-16 |
| 2018-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $312.00K derived: sum of 2 quarters · filed 2019-10-29 | $471.00K 10-Q · filed 2019-10-29 | $635.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $317.00K 10-Q · filed 2019-07-30 | $481.00K derived: sum of 3 quarters · filed 2020-02-25 | $647.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $159.00K 10-Q · filed 2019-04-30 | $323.00K derived: sum of 2 quarters · filed 2020-02-25 | $489.00K derived: sum of 3 quarters · filed 2020-02-25 | $656.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $330.00K derived: sum of 2 quarters · filed 2020-02-25 | $497.00K derived: sum of 3 quarters · filed 2020-02-25 | $662.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $333.00K derived: sum of 2 quarters · filed 2018-10-30 | $498.00K 10-Q · filed 2018-10-30 | $1.05M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $332.00K 10-Q · filed 2018-07-31 | $884.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.56M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $165.00K 10-Q · filed 2018-05-01 | $717.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.40M derived: sum of 3 quarters · filed 2019-02-26 | $2.07M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.23M derived: sum of 2 quarters · filed 2019-02-26 | $1.90M derived: sum of 3 quarters · filed 2019-02-26 | $2.58M 10-K · filed 2019-02-26 |
| 2016-09-30 | $679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.35M derived: sum of 2 quarters · filed 2017-10-31 | $2.02M 10-Q · filed 2017-10-31 | $2.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $1.34M 10-Q · filed 2017-08-01 | $2.02M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $672.00K 10-Q · filed 2017-05-02 | $1.35M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.69M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $2.01M 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $2.06M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |